A single blind, placebo controlled, across groups dose escalation study of the safety, tolerability, pharmacokinetics and pharmacodynamics of the melatonin analog β-methyl-6-chloromelatonin
- 27 August 2004
- journal article
- clinical trial
- Published by Elsevier BV in Life Sciences
- Vol. 75 (15), 1843-1856
- https://doi.org/10.1016/j.lfs.2004.03.023
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Effects of bright light and melatonin on sleep propensity, temperature, and cardiac activity at nightJournal of Applied Physiology, 2001
- The effects of oral melatonin on the autonomic function in healthy subjectsPsychiatry and Clinical Neurosciences, 2001
- Involvement of the 5-HT2 receptor in hyperthermia induced by p-chloroamphetamine, a serotonin-releasing drug in miceEuropean Journal of Pharmacology, 2000
- Peripheral Heat Loss: A Predictor of the Hypothermic Response to Melatonin Administration in Young and Older WomenPhysiology & Behavior, 1999
- Daytime melatonin and temazepam in young adult humans: equivalent effects on sleep latency and body temperaturesThe Journal of Physiology, 1999
- Sleep-Promoting Effects of Melatonin: At What Dose, in Whom, Under What Conditions, and by What Mechanisms?Sleep, 1997
- Improvement of sleep quality in elderly people by controlled-release melatoninThe Lancet, 1995
- The melatonin rhythm: both a clock and a calendarCellular and Molecular Life Sciences, 1993
- The effects of exogenous melatonin on the total sleep time and daytime alertness of chronic insomniacs: A preliminary studyBiological Psychiatry, 1991
- The effect of melatonin on normal sleepNeuropsychopharmacology, 1987